Table of Contents Why Cardiovascular Outcomes Matter in Diabetes Care Key Findings From 2025 Clinical Trials How New Therapies Like Ozempic, Jardiance, and Mounjaro Shape Cardiovascular Risk Implications for Clinical Practice and Patient Care Conclusion FAQs Why Cardiovascular Outcomes Matter in Diabetes Care Diabetes is one of the most significant risk factors for cardiovascular disease
Table 2 Baseline characteristics of CVOTs involving GLP-1 receptor agonists and key findings
The availability of oral semaglutide may help to broaden treatment options and facilitate the adoption of earlier treatment with arGLP-1 in the management of DM2
Sensations are brief and well tolerated, with integrated cooling maintaining comfort throughout
Tirzepatide (Mounjaro, Zepbound) works through a related but distinct mechanism as a dual GIP/GLP-1 receptor agonist
Handling & Reconstitution Reconstitute using bacteriostatic water Gently swirl until fully dissolved Use only within controlled research environments Follow standard sterile handling procedures Storage Guidelines Store lyophilised peptide in a cool, dry place away from light After reconstitution, refrigerate at 28C Avoid repeated freezethaw cycles Lyophilised shelf life: up to 24 months when stored correctly Important: Supplied strictly for research use only
